Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Let’s see if they can get over $1 and hold
Strong patent news but over extended seems like, slow day in the market tho and holding so let’s see
NCNA: I think this puppy is on the TOP of this list for SOME reason ---
https://www.benzinga.com/premarket
NCNA: News about Patent for Cancer treatment.
https://beststocks.com/title-nucana-receives-us-patent-for-phosphora/
NCNA: Here's today's (reclusive) NCNA Firm's Patent news item:
https://www.benzinga.com/wiim/24/03/37635513/nucana-shares-are-trading-higher-after-the-company-was-granted-u-s-patent-11925658-for-phosphoramida
"NuCana shares are trading higher after the company was granted U.S. Patent #11925658 for Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance"
NCNA: Unfortunately for ME, that's 1:00 a.m.!!! (I HATE San Diego!! By the Open, I get sloppy 3rd's, 4th's, or 5th's. I need WeBull, plus a stay-awake or 'Dracula-Drug'.)
NCNA: Cancer + England + Lots of Trials --- well, just may be a monster WINNING formula for Wednesday.
Move yesterday was probably due to anticipated presentations at a Cancer Therapeutics 2023 conference.
https://finance.yahoo.com/news/nucana-announces-presentations-aacr-nci-120000333.html
I think we see $4 soon enough. By the end of this week or next. IMO. $NCNA
Agreed. GL
$NCNA
This one is a no brainer.
Loaded heavy end of day. Looking forward to tomorrow here. $NCNA
Undervalued even after the massive gains this month. Do not underestimate the recent patent infringement ruling out of Germany. More to come. Stand by...
Just my conjecture but the recent news gave it momentum, for sure!
Nah....that's not the reason...just look up the company...you'll see why. Its recent news
Increasing volume and upward trend over the past 3 to 4 days could be indicative that the market may be sensing more FDA news or announcement in the short term. A good stock to hold IMHO.
NuCana Receives FDA Fast Track Designation For Acelarin (NUC-1031) For Treatment Of Biliary Tract Cancer.
Twice as many buys as sell on trading chart.
Go NCNA
Zacks Rank #1 (Strong Buy)
Will NuCana Continue To Surge Higher?
As of late, it has definitely been a great time to be an investor of NuCana plc NCNA.The stock has moved higher by nearly 11% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
We certainly think that this might be the case, particularly if you consider NCNA’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as NCNA has earned itself a Zacks Rank #1 (Strong Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.
NuCana Presenting at 2020 Jefferies Virtual Healthcare Conference
NuCana Presenting at 2020 Jefferies Virtual Healthcare Conference
Presentation Date: Wednesday, June 3, 2020
Presentation Time: 10:00 AM ET
About NuCana plc
NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients by applying our ProTide technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines. While these conventional agents remain part of the standard of care for the treatment of many solid and hematological tumors, their efficacy is limited by cancer cell resistance mechanisms and they are often poorly tolerated. Utilizing our proprietary technology, we are developing new medicines, ProTides, designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells.
NCNA Zacks Rank #1 Strong Buy
NCNA Zacks Rank #1 Strong Buy
Skip SANZERI Alersense
Hi, I am interested in investing in Nucana, PLC. Here is my background
Skip SANZERI has been an entrepreneur since 1996 beginning with Quote.com (backed by Sequoia). Skip Founded Myfamli - the world's first comprehensive family information and preservation system - myfamli.com Skip Founded AlerSense - The World’s First Smart Allergy, Asthma and COPD Air Quality Alert System. http://www.alersense.com/ Skip Sanzeri Exits: Merged InRange Technologies with CNT - Computer Network Technology Corp. Merged Open Source Group with Olliance Quote.com sold to Lycos IAC (Ziff Davis Division) sold to Thompson Educational Publishing Converted Gold's Gyms to California Athletic Clubs sold to 24 Hour Fitness
https://plus.google.com/+SkipSanzeri
https://www.facebook.com/sanzeri
https://www.slideshare.net/sanzeri
https://github.com/skipsanzeri
https://www.quora.com/profile/Skip-Sanzeri-1
https://www.spreaker.com/user/the_phoenix/interview-with-skip-sanzeri-of-alersense
Skip SANZERI shares with our listening audience pertinent information about his company AlerSense that is changing things regarding how allergens and harmful pollutants are detected to aid people with breathing difficulties. Skip is very passionate and dedicated to this project and shares from the depths of his heart. Tune in!!
Followers
|
15
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
118
|
Created
|
01/29/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |